Dr. Zavoral is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6545 France Ave S
Suite 291
Minneapolis, MN 55435Phone+1 952-924-1550
Education & Training
University of MinnesotaResidency, Pediatrics, 1967 - 1968
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1966 - 1967
HealthPartners Institute/Regions HospitalInternship, Transitional Year, 1965 - 1966- University of Minnesota Medical SchoolClass of 1965
Certifications & Licensure
MN State Medical License 1966 - 2025- American Board of Pediatrics Pediatrics
Clinical Trials
- The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
- Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia Start of enrollment: 2007 Jul 01
- 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia Start of enrollment: 2007 Oct 01
Publications & Presentations
PubMed
- 19 citationsSerum lipid and fecal bile acid changes with cereal, vegetable, and sugar-beet fiber feedingJohanna W. Lampe, Joanne L. Slavin, Kim S. Baglien, William O. Thompson, William C. Duane
The American Journal of Clinical Nutrition. 1991-05-01 - 187 citationsOrlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y studyJames O. Hill, Jonathan Hauptman, James W. Anderson, Ken Fujioka, Patrick M. O'Neil
The American Journal of Clinical Nutrition. 1999-06-01 - 66 citationsTreatment with orlistat reduces cardiovascular risk in obese patientsJames H. Zavoral
Journal of Hypertension. 1998-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
